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Efficacy, safety and tolerability by age

  n (%)                             Week 48\<50          Week 48≥50         Week 96\<50          Week 96≥50         Week 144\<50         Week 144≥50
  --------------------------------- -------------------- ------------------ -------------------- ------------------ -------------------- ------------------
  STB versus ATR                                                                                                                         
  Virologic success (VS)            263 (88); 250 (84)   42 (86); 46 (82)   253 (85); 241 (81)   40 (82); 46 (82)   241 (81); 221 (75)   38 (78); 44 (79)
  Virologic failure (VF)            23 (8); 23 (8)       2 (4); 2 (4)       20 (7); 24 (8)       2 (4); 3 (5)       23 (8); 30 (10)      3 (6); 4 (7)
  Mean change in CD4, cells/mm^3^   246; 208             199; 194           305; 278             233; 250           325; 304             295; 280
  AEs Leading to DC                 10 (3); 12 (4)       3 (6); 6 (11)      12 (4); 18 (6)       5 (10); 6 (11)     16 (5); 20 (7)       5 (10); 6 (11)
  Median change in eGFRCG, mL/min   −14.8; −1.6          −12.0; −7.5        −13.9; 0.4           −12.9; −8.2        −15.2; −0.3          −18.2; −8.7
  STB versus ATV+RTV+TVD                                                                                                                 
  VS                                271 (89); 266 (87)   45 (94); 42 (88)   251 (82); 249 (81)   43 (90); 43 (90)   236 (77); 228 (74)   38 (79); 37 (77)
  VF                                17 (6); 17 (6)       2 (4); 2 (4)       22 (7); 25 (8)       2 (4); 1 (2)       25 (8); 25 (8)       3 (6); 1 (2)
  Mean change in CD4, cells/mm^3^   212; 213             176; 200           261; 266             226; 231           285; 300             245; 256
  AEs Leading to DC                 12 (4); 15 (5)       1 (2); 3 (6)       13 (4); 17 (6)       2 (4); 4 (8)       17 (6); 21 (7)       4 (8); 9 (19)
  Median change in eGFRCG, mL/min   −13.4; −10.0         −10.2; −7.3        −12.5; −8.8          −11.1; −12.6       −12.9; −9.4          −13.5; −12.9
